Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective.

Abstract:

:It is well known that women with systemic lupus erythematosus (SLE) who have antiphospholipid antibodies (aPL) are at increased risk for pregnancy loss. Additionally, other reproductive processes, such as unexplained infertility and implantation failure after in vitro fertilization and embryo transfer may be affected by aPL. Thus, clinical manifestations of the so-called 'gynaeco-obstetrical antiphospholipid syndrome' have been expanded into the concept of the 'reproductive autoimmune failure syndrome'. However, this is still a matter of debate with no general agreement with respect to both pathophysiological significance of the presence of aPL and patient management. This article analyses a number of controversies in the management of reproductive failure potentially associated with aPL in order to help clinicians dealing with such condition in daily clinical practice.

journal_name

Lupus

journal_title

Lupus

authors

Balasch J,Cervera R

doi

10.1191/0961203302lu237ra

subject

Has Abstract

pub_date

2002-01-01 00:00:00

pages

467-77

issue

8

eissn

0961-2033

issn

1477-0962

journal_volume

11

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Repeated miscarriages in patients with antiphospholipid syndrome and subjected to in vitro fertilization: the importance of preimplantation genetic diagnosis.

    abstract::The aim of this study was to investigate two patients with antiphospholipid syndrome (APS) who suffered from multiple repeated pregnancy losses of probably genetically impaired embryos. Sera from these patients contained high levels of IgG antibodies against cardiolipin, IgG and IgM phosphatidyl inositol, IgG phosphat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312442581

    authors: Ulcova-Gallova Z

    更新日期:2012-06-01 00:00:00

  • Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.

    abstract::Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920118

    authors: de Groot K,Gross WL

    更新日期:1998-01-01 00:00:00

  • Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review.

    abstract::Cytomegalovirus (CMV) is particularly dangerous in systemic lupus erythematosus (SLE), being a problem both for the differential diagnosis with disease flare and for the management of SLE flare with immunosuppressive drugs. We report on four cases of SLE with concomitant CMV infection, having some common clinical and ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319825570

    authors: Sebastiani GD,Iuliano A,Canofari C,Bracci M

    更新日期:2019-03-01 00:00:00

  • Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.

    abstract::The objective of this article was to evaluate whether serum uric acid (SUA) correlates with arterial stiffness and inflammation markers in a cohort of women with systemic lupus erythematosus (SLE) without overt atherosclerotic cardiovascular diseases, who attended a community hospital. One hundred and two women with S...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309355301

    authors: Sabio JM,Vargas-Hitos JA,Mediavilla JD,Navarrete-Navarrete N,Zamora-Posadas M,Pérez-Vicente S,Hidalgo-Tenorio C,Díaz-Chamorro A,Jáimez L,Jiménez-Alonso J,Grupo Lupus Virgen de las Nieves.

    更新日期:2010-04-01 00:00:00

  • The lupus patient with positive rheumatoid factor.

    abstract::Background Patients with systemic lupus erythematosus (SLE) may form clusters with clinical manifestations and autoantibodies. Objective The objective of this report is to study whether SLE patients with positive rheumatoid factor (RF) have a special clinical and/or serological profile. Methods A retrospective study o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318759607

    authors: Fedrigo A,Dos Santos TAFG,Nisihara R,Skare T

    更新日期:2018-07-01 00:00:00

  • Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience.

    abstract:OBJECTIVE:To evaluate the occurrence of idiopathic intracranial hypertension (IIH) in patients with systemic lupus erythematosus (SLE) and to describe the manifestations, treatments and outcomes in these patients. METHODS:We reviewed the medical records of 1084 patients with SLE followed up from January 1997 to June 2...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311435267

    authors: Kim JM,Kwok SK,Ju JH,Kim HY,Park SH

    更新日期:2012-04-01 00:00:00

  • Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.

    abstract::The objective of this study is to investigate the presence of anti-nucleosome (anti-NCS) and anti-chromatin (anti-CRT) antibodies in patients with cutaneous lupus erythematosus (CLE) compared with active and inactive systemic lupus erythematosus (SLE). A total of 154 subjects were evaluated: 54 patients presenting CLE...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308096255

    authors: Souza A,da Silva LM,Oliveira FR,Roselino AM,Louzada-Junior P

    更新日期:2009-03-01 00:00:00

  • Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.

    abstract::The levels of 'putative' anti-idiotypic antibodies reactive with F(ab')2 fragments of affinity purified DNA binding antibodies from five SLE patients were measured in the serum of active and inactive systemic lupus erythematosus (SLE) patients, their relatives, spouses and healthy non-related individuals. Serum anti-i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678919958

    authors: Williams WM,Isenberg DA

    更新日期:1998-01-01 00:00:00

  • Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

    abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315598018

    authors: Yap DY,Yung S,Zhang Q,Tang C,Chan TM

    更新日期:2016-01-01 00:00:00

  • Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

    abstract:INTRODUCTION:Anti-RNP autoantibodies occur either in mixed connective tissue disease (MCTD) (with a frequently favorable prognosis), or in systemic lupus erythematosus (SLE) cases with aggressive major organ disease. It is uncertain how to assess for the risk of severe disease in anti-RNP + patients. METHODS:Following...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315575586

    authors: Carpintero MF,Martinez L,Fernandez I,Romero AC,Mejia C,Zang YJ,Hoffman RW,Greidinger EL

    更新日期:2015-09-01 00:00:00

  • A case of drug-induced lupus erythematosus secondary to trimethoprim/sulfamethoxazole presenting with pleural effusions and pericardial tamponade.

    abstract::We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657435

    authors: Jose A,Cramer AK,Davar K,Gutierrez G

    更新日期:2017-03-01 00:00:00

  • Entheseal involvement in systemic lupus erythematosus: are we missing something?

    abstract::Background Musculoskeletal involvement is extremely common in patients with systemic lupus erythematosus (SLE). Continuing the research initiated in patients with inflammatory arthritis, recent studies have shown the potential role of musculoskeletal ultrasound (MSUS) in the evaluation of clinical and subclinical lupu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316662723

    authors: Di Matteo A,Satulu I,Di Carlo M,Lato V,Filippucci E,Grassi W

    更新日期:2017-03-01 00:00:00

  • Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.

    abstract::Integrin very late antigen-4 (VLA4) is induced during inflammation and can regulate monocyte migration. It has been implicated in atherogenesis, a significant concern in systemic lupus erythematosus (SLE). The aim of this study was to define VLA4 expression in SLE monocytes. Flow cytometry, reverse transcription polym...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313475691

    authors: Rahimi H,Maurer K,Song L,Akhter E,Petri M,Sullivan KE

    更新日期:2013-03-01 00:00:00

  • Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy.

    abstract::We report the occurrence of visceral leishmaniasis in three patients coming from the northern part of Italy treated with immunosuppressive drugs for different rheumatic conditions. This paper highlights the importance of adequate work-up in those patients presenting with serious clinical manifestations that can compli...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu518oa

    authors: Castellino G,Govoni M,Lo Monaco A,Montecucco C,Colombo F,Trotta F

    更新日期:2004-01-01 00:00:00

  • Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

    abstract::We examined the prevalence of clinical and immunologic features of systemic lupus erythematosus (SLE) by race, sex and age in a population-based study of 265 SLE patients. Patients fulfilled the American College of Rheumatology classification criteria. The median time between diagnosis and study enrollment was 13 mont...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1191/0961203302lu161oa

    authors: Cooper GS,Parks CG,Treadwell EL,St Clair EW,Gilkeson GS,Cohen PL,Roubey RA,Dooley MA

    更新日期:2002-01-01 00:00:00

  • Bilateral choroidopathy in systemic lupus erythematosus.

    abstract::We report a case of bilateral choroidopathy in a 35-year-old woman with systemic lupus erythematosus (SLE) diagnosed 3 years previously, and treated with hydroxychloroquine and steroids that ceased 6 months before ocular signs. She complained about rapid bilateral blurred vision with a severe loss of visual acuity. Fl...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311398510

    authors: Edouard S,Douat J,Sailler L,Arlet P,Astudillo L

    更新日期:2011-10-01 00:00:00

  • Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.

    abstract:INTRODUCTION:Complement activation is central to the pathogenesis of lupus nephritis (LN). Low serum complement C3 and C4, are traditionally used as markers of lupus disease activity in general and LN in particular. In this study we prospectively measured plasma and urine C3d and C4d, degradation products of C3 and C4 ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320950019

    authors: Ganguly S,Majumder S,Kumar S,Gupta R,Muhammed H,Shobha V,Aggarwal A,Misra R

    更新日期:2020-11-01 00:00:00

  • A case of lupus erythematosus profundus with multiple arc-shaped erythematous plaques on the scalp and a review of the literature.

    abstract::A 26-year-old Japanese female presented to us with a 2-year history of multiple arc-shaped erythematous lesions on her scalp and the right side of her forehead. Histopathological examination of two of the lesions showed lobular and septal panniculitis with deposits of IgG in the basement membrane zone. We diagnosed th...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311433917

    authors: Tsuzaka S,Ishiguro N,Akashi R,Kawashima M

    更新日期:2012-05-01 00:00:00

  • The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome.

    abstract::The importance of the immunomodulatory effects of vitamin D has recently been associated with autoimmune and chronic inflammatory diseases. Vitamin D deficiency has been linked to the development of autoimmune conditions. Antiphospholipid syndrome is an autoimmune disease characterized by thrombotic events and obstetr...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318801520

    authors: García-Carrasco M,Jiménez-Herrera EA,Gálvez-Romero JL,Mendoza-Pinto C,Méndez-Martínez S,Etchegaray-Morales I,Munguía-Realpozo P,Vázquez de Lara-Cisneros L,Santa Cruz FJ,Cervera R

    更新日期:2018-12-01 00:00:00

  • Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China.

    abstract::Objective Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus nephritis might be different. Methods This study enrolled 334 lupus nephr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317702254

    authors: Tan M,Hao JB,Chu H,Wang FM,Song D,Zhu L,Yu F,Li YZ,Song Y,Zhao MH

    更新日期:2017-10-01 00:00:00

  • Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

    abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1191/0961203303lu440oa

    authors: Strand V,Aranow C,Cardiel MH,Alarcón-Segovia D,Furie R,Sherrer Y,Tumlin J,Wallace DJ,Crawford B,LJP 394 Investigator Consortium.

    更新日期:2003-01-01 00:00:00

  • Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus.

    abstract::Skin involvement in systemic lupus erythematosus (SLE) occurs in varied forms. Lupus erythematosus tumidus (LET) is not known to occur with SLE. In our patient presented below, LET occurred in a patient with SLE. Some of the lesions progressed to scarring discoid lesions, while others responded very well to hydoxychlo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu473cr

    authors: Jolly M,Laumann AE,Shea CR,Utset TO

    更新日期:2004-01-01 00:00:00

  • Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

    abstract::Vaccination has been perhaps the most important achievement in medicine of the last century. A hoard of infectious diseases that used to claim the lives of many, especially children, have been prevented and some even eradicated. However, it is possible that within this gift there is hidden a 'Trojan Horse'. During the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301673085478

    authors: Aron-Maor A,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

    abstract:OBJECTIVE:The feed-forward loop of type I interferons (IFNs) production and subsequent immunopathology of systemic lupus erythematosus (SLE) has been hypothesised to be disrupted with inhibition of IFNα or type I IFN receptor subunit 1 (IFNAR). This systematic review and meta-analysis present the treatment efficacy and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320959702

    authors: Koh JWH,Ng CH,Tay SH

    更新日期:2020-12-01 00:00:00

  • Vitamin D insufficiency in a large female SLE cohort.

    abstract::The objective of this study was to determine the vitamin D status and its relationship with disease and therapy features and with bone mineral density in women with systemic lupus erythematosus. Non-pregnant systemic lupus erythematosus women with dual-energy X-ray absorptiometry and vitamin D measurements performed b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345775

    authors: Toloza SM,Cole DE,Gladman DD,Ibañez D,Urowitz MB

    更新日期:2010-01-01 00:00:00

  • Primary anetoderma: a cutaneous sign of antiphospholipid antibodies.

    abstract::Although a few reports in recent years have suggested that patients with antiphospholipid antibodies (aPL) are prone to developing primary anetoderma (PA), it is still unclear how often aPL are detected in unselected PA patients. We studied nine consecutive PA patients for the presence of autoimmune antibodies and dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu403oa

    authors: Hodak E,Feuerman H,Molad Y,Monselise Y,David M

    更新日期:2003-01-01 00:00:00

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    abstract:OBJECTIVE:To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). METHODS:A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated primarily by nephritis, serositis or hematological abnormalities. In additi...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/096120399678847588

    authors: van Vollenhoven RF,Park JL,Genovese MC,West JP,McGuire JL

    更新日期:1999-01-01 00:00:00

  • High-dose cyclophosphamide for severe systemic lupus erythematosus.

    abstract::Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here we report on our first four patients treated for severe SLE with this ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203302lu229oa

    authors: Gladstone DE,Prestrud AA,Pradhan A,Styler MJ,Topolsky DL,Crilley PA,Hoch S,Huppert A,Brodsky I

    更新日期:2002-01-01 00:00:00

  • Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus.

    abstract::CD27 is a useful marker in assessing the number of circulating B cells and B cell subsets because it permits one step identification of the major B cell compartments, CD27- naïve and CD27+ memory B cells as well as CD27high plasma cells. Abnormalities in the distribution ofCD27+ B cell subsets are useful in assessing ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203304lu1014oa

    authors: Dörner T,Lipsky PE

    更新日期:2004-01-01 00:00:00

  • Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

    abstract::Vaccines have undoubtedly brought overwhelming benefits to mankind and are considered safe and effective. Nevertheless, they can occasionally stimulate autoantibody production or even a recently defined syndrome known as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is scarce data regarding autoi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311429817

    authors: Perdan-Pirkmajer K,Thallinger GG,Snoj N,Čučnik S,Žigon P,Kveder T,Logar D,Praprotnik S,Tomšič M,Sodin-Semrl S,Ambrožič A

    更新日期:2012-02-01 00:00:00